The future is now: Using the lessons learned from the ACTIV COVID-19 therapeutics trials to create an inclusive and efficient clinical trials enterprise

• Stacey J. Adam,
• Sarah E. Dunsmore,
• Lisa H. Merck,
• Sarah W. Read,
• Yves Rosenberg

Affiliations

Stacey J. Adam

ORCiD

Foundation for the National Institutes of Health, North Bethesda, USA

Sarah E. Dunsmore

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, USA

Lisa H. Merck

Department of Emergency Medicine, Virginia Commonwealth University, Richmond, Virginia, USA

Sarah W. Read

ORCiD

National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA

Yves Rosenberg

National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA